These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19396726)

  • 1. Circadian rhythm of neutrophil counts and granulocyte macrophage-colony stimulating factor (GM-CSF) under clozapine treatment: a case report.
    Ferrea S; Fehsel K; Cordes J; Luckhaus C
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):511-3. PubMed ID: 19396726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
    Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
    J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF and the management of clozapine-induced agranulocytosis.
    Gerson SL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma.
    Dinçol D; Samur M; Pamir A; Sencan O; Akbulut H; Yalçin B; Onur H; Demirkazik A; Senler FC; Içli F
    Cancer; 2000 May; 88(9):2033-6. PubMed ID: 10813713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
    Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O
    Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels.
    Pollmächer T; Fenzel T; Mullington J; Hinze-Selch D
    Pharmacopsychiatry; 1997 Jul; 30(4):118-21. PubMed ID: 9271776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
    Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
    Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
    Hurtado R; Candelaria M; Majluf-Cruz A; Sosa-Camas RE; Labardini-Méndez J
    Rev Invest Clin; 1994; 46(1):59-61. PubMed ID: 8079066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal variations of serum GM-CSF levels.
    Dinçol D; Akbulut H; Büyükçelik A; Içli F
    Cytokine; 2000 Jul; 12(7):1151-5. PubMed ID: 10880267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ; Ramlal D
    Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
    Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
    Nienhuis AW; Donahue RE; Karlsson S; Clark SC; Agricola B; Antinoff N; Pierce JE; Turner P; Anderson WF; Nathan DG
    J Clin Invest; 1987 Aug; 80(2):573-7. PubMed ID: 3301903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.